{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T01:15:03Z","timestamp":1740100503122,"version":"3.37.3"},"reference-count":15,"publisher":"IEEE","license":[{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/ieeexplore.ieee.org\/Xplorehelp\/downloads\/license-information\/IEEE.html"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T00:00:00Z","timestamp":1639008000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"}],"funder":[{"DOI":"10.13039\/100018696","name":"Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018696","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,9]]},"DOI":"10.1109\/bibm52615.2021.9669536","type":"proceedings-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T20:40:30Z","timestamp":1642192830000},"page":"2014-2021","source":"Crossref","is-referenced-by-count":0,"title":["Leveraging Drug-Target Interaction Data for the Translation of Computational Models into Clinically Actionable Interventions"],"prefix":"10.1109","author":[{"given":"Spencer C.","family":"Richmanz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole A.","family":"Lyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbao","family":"Caoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia","family":"Nesterovay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton","family":"Yuryevy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Cheadley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Broderick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"263","reference":[{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/14786448808628170"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1814092116"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100591","article-title":"Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)","volume":"28","author":"guisado-vasco","year":"2020","journal-title":"EClinicalMedicine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2174\/1381612822666160224142812"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.drudis.2016.05.015","article-title":"Drug combination therapy in-creases successful drug repositioning","volume":"21","author":"wei","year":"2016","journal-title":"Drug Discov Today"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02520-12"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1109\/BIBE50027.2020.00080"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2350"},{"key":"ref5","first-page":"1031d","article-title":"Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics","volume":"48","author":"wang","year":"2020","journal-title":"Nucleic Acids Research"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1086\/341527"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa1027"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022926"},{"journal-title":"Memorandum Explaining Basis for Revocation of Emergency Use Authorization for Emergency Use of Chloroquine Phosphate and Hydroxychloroquine Sulfate","year":"2020","key":"ref1"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"}],"event":{"name":"2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)","start":{"date-parts":[[2021,12,9]]},"location":"Houston, TX, USA","end":{"date-parts":[[2021,12,12]]}},"container-title":["2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)"],"original-title":[],"link":[{"URL":"http:\/\/xplorestaging.ieee.org\/ielx7\/9669261\/9669139\/09669536.pdf?arnumber=9669536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T16:57:18Z","timestamp":1652201838000},"score":1,"resource":{"primary":{"URL":"https:\/\/ieeexplore.ieee.org\/document\/9669536\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":15,"URL":"https:\/\/doi.org\/10.1109\/bibm52615.2021.9669536","relation":{},"subject":[],"published":{"date-parts":[[2021,12,9]]}}}